通过机器学习驱动的发现,在抗CRISPR蛋白中发现了基本结合偏好
QingLan Ma1, YuHang Zhang2, Lei Chen3
1School of Life Sciences, Shanghai University, Shanghai, China.
Proteomics. Clinical applications
|July 1, 2025
概括
研究人员确定了抗CRISPR蛋白质的关键分子特征,这些蛋白质可以逃避CRISPR-Cas免疫力. 这一发现有助于理解抗CRISPR机制,并设计基于CRISPR的先进生物技术工具.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 生物技术是生物技术.
背景情况:
- 克里斯普尔-卡斯系统在细菌和古生物中提供适应性免疫力.
- 克里斯普尔-Cas9技术是现代基因组编辑的基石.
- 抗CRISPR蛋白 (Acrs) 抑制CRISPR-Cas活性,有助于菌体的生存.
研究的目的:
- 为了确定负责抗CRISPR蛋白活性的分子决定因素.
- 推进对ACR机制的基本理解.
- 为基于CRISPR的增强工具的合理设计提供信息.
主要方法:
- 编制了761个InterPro注释域的数据集,以及已知Acr蛋白的结合点特征.
- 应用了七个特征排名算法和四个分类器的增量特征选择.
- 通过在所有方法中交叉最佳子集来确定共识的关键特征.
主要成果:
- 确定了关键特征,包括DUF2829,Lambda压缩器类域和Cro/C1型螺旋转螺旋域.
- 突出了Sulfolobus islandicus病毒蛋白质,菌体蛋白质和复制启动器A的作用.
- 揭示了Acr抑制背后的新型结构模块和监管动机.
结论:
- 提供解密反CRISPR机制的理论支持.
- 为设计下一代CRISPR-Cas应用提供了可操作的见解.
- 通过使用CRISPR技术,促进临床和生物技术环境的进步.
更多相关视频
07:08Optimization of Synthetic Proteins: Identification of Interpositional Dependencies Indicating Structurally and/or Functionally Linked Residues
Published on: July 14, 2015
7.4K
11:34Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins
Published on: August 9, 2019
6.8K
相关概念视频
Conserved Binding Sites
4.4K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.4K
Protein-protein Interfaces
13.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
13.5K
Ligand Binding Sites
13.4K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
13.4K
Ligand Binding and Linkage
4.9K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.9K
The Equilibrium Binding Constant and Binding Strength
13.8K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
13.8K
Allosteric Proteins-ATCase
5.9K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.9K
